Axokine: Began Phase II trial

Regeneron Pharmaceuticals Inc. (REGN), Tarrytown, N.Y. Product: Axokine Business: Metabolic Therapeutic category: Metabolism, Growth factor Target: CNTF receptors Description: Second generation cilia...